Farallon Capital Management LLC Editas Medicine, Inc. Transaction History
Farallon Capital Management LLC
- $18.8 Billion
- Q4 2024
Shares
2 transactions
Others Institutions Holding EDIT
# of Institutions
228Shares Held
54.2MCall Options Held
412KPut Options Held
355K-
Black Rock Inc. New York, NY7.78MShares$10.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.82MShares$8.94 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.75MShares$3.6 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.16MShares$2.83 Million0.0% of portfolio
-
State Street Corp Boston, MA1.87MShares$2.45 Million0.0% of portfolio
About Editas Medicine, Inc.
- Ticker EDIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,737,200
- Market Cap $90M
- Description
- Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...